NEW YORK (GenomeWeb) – Researches from Tufts Medical Center and other institutions working with Illumina have published a new study in which they identified a total of 10 cases of maternal cancer in women who received a discordant or false-positive result after Illumina's non-invasive prenatal testing.
The data, which appeared yesterday in JAMA, represent a retrospective analysis of over 125,000 samples tested by Illumina between February 2012 and September 2014.